medicare glp-1 Bridge Program Explained: Medications for Weight Loss 🚨 BIG NEWS FOR MEDICARE

Even if employers adopted a BMI threshold of 35 or greater, 13% (14.6 million) of adults under 65 covered by an employer plan would exceed this threshold

Study findings Database searches identified 5,136 records, with four additional records identified from other sources

PMCID: PMC9428699

Encourage patients to verify coverage before their visit

The theoretical benefits of low-dose GLP-1 therapy for inflammation include the potential for anti-inflammatory effects with a reduced side effect burden compared to standard doses

Key Considerations for Patients on Weight Loss Medications (Mounjaro/Wegovy) Before Surgery Many patients are using GLP-1 medications such as Semaglutide (Wegovy) or Tirzepatide (Mounjaro) to support weight loss